The current prices are delayed, login to your account for live prices
Login

Logo

GENPHARMASEC LIMITED Share Price

531592
₹ 1.28
+₹0.06 (4.92%)
1D
Last updated 25 May, 2026, 15:29 IST
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target

₹1.28
4.92% up in 1Day
₹1.28
1D LOW
1D HIGH
Open
1.28
High
1.28
Low
1.28
Prev. close
1.22

Circuit
L
H
₹1.16
₹1.28
52-week
L
H
₹0.75
₹2.33

Shareholder Returns

Share Price History

Mkt Cap Cr
67.55

P/E
122

P/B
1.02

ROE
2.42%

D/E
0.07

ROCE
2.18%

Div. Yield

EPS(TTM)
0.1
Turnover

EV/EBITDA
21.15

Net Margin
0%

Op. Margin
0%

ROA
0.41%

Quick Ratio
0

Curr. Ratio
1.84
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Step 1 of 5
Valuation
Overvalued
Step 4 of 5
Earnings
Good

Financials

Full statement

Consolidated - Yearly
All values are in INR Crore
Consolidated
Annually
* All values are in INR Crore
Qty
Bid
384888
1.28
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 384888
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
Indicator
Value
Verdict

RSI (14)
54.86
Neutral

ATR (14)
0.06
Neutral

STOCH(9,6)
81.25
Bearish

STOCH RSI (14)
73.9
Neutral

ADX(9)
16.73
Bullish

UO(9)
54.16
Neutral

ROC(12)
-1.61
Bearish

WillR(14)
-38.1
Neutral
Period
Simple value
Exponential vaue

5D
1.17
1.18

10D
1.17
1.18

20D
1.21
1.18

50D
1.12
1.18

100D
1.19
1.24
About GENPHARMASEC LIMITED
GENPHARMASEC LIMITED logo
NSE Symbol
BSE Symbol
BSE: 531592
ISIN
INE861N01036
Sector Market Cap
₹ 67.55 Cr

Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.As of 25 May 2026, GENPHARMASEC LIMITED share price is ₹1.28. The stock opened at ₹1.28, compared to its previous close of ₹1.22. During today's trading session, GENPHARMASEC LIMITED share price moved in the range of ₹1.28 to ₹1.28, with an average price of ₹1.28 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.28 and a high of ₹1.28.

The market capitalization of GENPHARMASEC LIMITED is ₹68 Crs, with a P/E ratio of 122.0 and a dividend yield of 0.00%.

Frequently Asked Questions